Oncovir, Inc. Alternatives & Competitors
6 companies similar to Oncovir, Inc. — Activating Innate & Adaptive Immunity
Companies similar to Oncovir, Inc.
Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Houston, United States
Replicor Inc.
292 million people have chronic hepatitis B. We're developing the cure.
Montreal, Canada
Revitope
Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more...
Cambridge, United States
Track all Oncovir, Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Invirsa, Inc
A Phase 3 ready clinical-stage ophthalmology company pioneering the world's first DNA Repa...
Columbus, United States
Valo Therapeutics Ltd
Reinventing Cancer Immunotherapy
Helsinki, Finland
About Oncovir, Inc.
Oncovir, Inc. is a biotechnology startup founded in 1998, specializing in nucleic-acid-based clinical therapies for cancer, infectious, immune, and degenerative disorders. The company's slogan, "Activating Innate & Adaptive Immunity," aligns with its core mission of promoting Hiltonol® (poly-ICLC) as an experimental vi...
Pharmaceuticals, Nucleic-Acid-Based Therapies, Cancer Therapies, Immunotherapy, Infectious Disorders, Immune Activation, Vaccine Adjuvant, Antiviral Therapies, Antitumor Actions, Degenerative Disorders, Clinical Therapies, Biological Effects, Interferon Inducer, Viral Mimic, Innate Immunity
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Oncovir, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Oncovir, Inc. on 18 Nov 2024. The 6 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
